Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.874 USD | -0.46% | +0.03% | +4.32% |
Apr. 24 | BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals | MT |
Apr. 24 | BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals | AN |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 126 | 100.0 % | 214 | 100.0 % | +69.13% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 126 | 100.0 % | 214 | 100.0 % | +69.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Investment Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Hyman
CHM | Chairman | 67 | 17-02-26 |
Duncan Budge
BRD | Director/Board Member | 68 | - |
Director/Board Member | - | 18-12-04 | |
Colin Bond
BRD | Director/Board Member | 64 | 16-10-31 |
Rolf Soderstrom
BRD | Director/Board Member | 58 | 20-09-15 |
Sapna Shah
BRD | Director/Board Member | - | 23-03-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,297,702,331 | 1,150,748,367 ( 88.68 %) | 71,252,875 ( 5.491 %) | 88.68 % |
Company contact information
1st Jan change | Capi. | |
---|---|---|
+4.32% | 1.08B | |
+3.74% | 12.61B | |
+7.11% | 9.01B | |
-3.20% | 5.41B | |
+2.44% | 5.25B | |
+5.63% | 5.19B | |
+14.36% | 4.48B | |
+16.67% | 4.44B | |
+1.53% | 4B | |
+1.65% | 3.75B |
- Stock Market
- Equities
- BPCP Stock
- Company BioPharma Credit PLC